Senior insider sale
See Remarks at NEUMORA THERAPEUTICS, INC. — senior position signals high conviction
$220.1K
146.71K shares
What this filing means
AURORA DALJIT SINGH plans to sell 146.71K shares of NEUMORA THERAPEUTICS, INC. valued at approximately $220.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/17/2026ACC: 0001964306-26-000398
Officer· See Remarks
Since Feb 2026
146.71K
Shares to sell
$220.1K
Approx. market value
146.71K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Exercise of employee stock options
Broker assisted cashless sale
8/17/2026
112.69KVesting of restricted stock unit awards
Granted as part of issuer equity compensation plan
2/14/2026
24.38KVesting of restricted stock unit awards
Granted as part of issuer equity compensation plan
2/14/2025
9.64KTotal acquired146.71K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/17/2026 | Exercise of employee stock options Broker assisted cashless sale | 112.69K | — |
2/14/2026 | Vesting of restricted stock unit awards Granted as part of issuer equity compensation plan | 24.38K | — |
2/14/2025 | Vesting of restricted stock unit awards Granted as part of issuer equity compensation plan | 9.64K | — |
| Total | 146.71K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
146.71K
Market value
$220.1K
8/17/2026
Total
Units
146.71K
Value
$220.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/17/2026 | 146.71K | $220.1K | NASDAQ | Planned |
| Total | 146.71K | $220.1K | ||